Status:
UNKNOWN
Does Mirabegron Have a Positive Impact on Sexual Function in Females With Overactive Bladder
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Females With Overactive Bladder Symptoms, Urgency & Urge Incontinence
Eligibility:
FEMALE
Brief Summary
80 female patients evaluated for sexual function after receiving Mirabegron 50 mg once daily for 6 months for treatment of overactive bladder symptoms
Detailed Description
80 female patients evaluated for sexual function after receiving Mirabegron 50 mg once daily for 6 months for treatment of overactive bladder symptoms
Eligibility Criteria
Inclusion
- any female with overactive bladder symptoms, urgency and urgency incontinence
Exclusion
- neurologic abnormalities
- Weak bladder contractility
- Diabetics
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04511273
Start Date
September 1 2020
End Date
April 1 2021
Last Update
August 13 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.